Obstetric Results After Fertility-Sparing Management of Non-Epithelial Ovarian Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Aug 26

PMID 37627198

Authors

Szymon Piatek

Iwona Szymusik

Piotr Sobiczewski

Wojciech Michalski

Magdalena Kowalska

Mariusz Oltarzewski

Mariusz Bidzinski

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess the recurrence and birth rates among patients with non-epithelial ovarian cancer.

Methods: The study included 146 patients with germ cell (GCT, n = 84) and sex cord-stromal tumors (SCST, n = 62), who underwent fertility-sparing surgery. Adjuvant chemotherapy was administered to 86 (58.9%) patients. Most cases (133 out of 146) were staged FIGO I.

Results: The 5- and 10-year disease-free survival rates were 91% and 83%, respectively. The recurrence risk was not associated with tumor histology, stage or age. Twenty-four months after the treatment, the rate of recurrence was higher than the rate of childbearing. The childbearing rates kept rising after the treatment and exceeded the rate of recurrence after 2 years. The cumulative incidence rates of birth 36, 60 and 120 months after treatment were 13.24%, 20.75%, and 42.37%, respectively. Chemotherapy was not related to childbearing. The patients' age was related to the chance of childbearing.

Conclusions: The prognoses of GCT and SCST are similar. Close follow-ups along with contraception should be offered to women during the first two years after treatment due to the increased risk of recurrence. After this period, relapses are rare and women can safely become pregnant.

References

Dellino M, Silvestris E, Loizzi V, Angelo Paradiso , Loiacono R, Minoia C . Germinal ovarian tumors in reproductive age women: Fertility-sparing and outcome. Medicine (Baltimore). 2020; 99(39):e22146. PMC: 7523774. DOI: 10.1097/MD.0000000000022146. View

Chan J, Tewari K, Waller S, Cheung M, Shin J, Osann K . The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008; 98(2):111-6. PMC: 4111627. DOI: 10.1002/jso.21079. View

Cheung A, Shah S, Parker J, Soor P, Limbu A, Sheriff M . Non-Epithelial Ovarian Cancers: How Much Do We Really Know?. Int J Environ Res Public Health. 2022; 19(3). PMC: 8834485. DOI: 10.3390/ijerph19031106. View

Negri S, Grassi T, Fruscio R . Use of staging for sex cord stromal tumours. Curr Opin Oncol. 2022; 34(5):504-510. PMC: 9415218. DOI: 10.1097/CCO.0000000000000860. View

Piatek S, Szymusik I, Danska-Bidzinska A, Oltarzewski M, Trojan G, Bidzinski M . Fertility-Sparing Management May Be Considered in Young Women with Uterine Sarcoma. J Clin Med. 2022; 11(16). PMC: 9410102. DOI: 10.3390/jcm11164761. View

Johansen G, Dahm-Kahler P, Staf C, Radestad A, Rodriguez-Wallberg K . Fertility-sparing surgery for treatment of non-epithelial ovarian cancer: Oncological and reproductive outcomes in a prospective nationwide population-based cohort study. Gynecol Oncol. 2019; 155(2):287-293. DOI: 10.1016/j.ygyno.2019.08.017. View

Nasioudis D, Kanninen T, Holcomb K, Sisti G, Witkin S . Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors. Gynecol Oncol. 2017; 145(2):243-247. DOI: 10.1016/j.ygyno.2017.03.005. View

Gershenson D . Management of ovarian germ cell tumors. J Clin Oncol. 2007; 25(20):2938-43. DOI: 10.1200/JCO.2007.10.8738. View

Turan V, Lambertini M, Lee D, Wang E, Clatot F, Karlan B . Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2021; 39(18):2016-2024. PMC: 8260903. DOI: 10.1200/JCO.20.02880. View

10.

Wang D, Cang W, Zhu S, Jia C, Cao D, Yang J . Oncological and Reproductive Outcomes in Patients With Advanced-Stage Ovarian Immature Teratoma: Experience From a Tertiary Center. Front Oncol. 2022; 12:822341. PMC: 9257032. DOI: 10.3389/fonc.2022.822341. View

11.

Yang B, Yu Y, Chen J, Zhang Y, Yin Y, Yu N . Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant-a Chinese retrospective cohort study among 148 cases. Front Med. 2017; 12(5):509-517. DOI: 10.1007/s11684-017-0554-3. View

12.

Haroon S, Zia A, Idrees R, Memon A, Fatima S, Kayani N . Clinicopathological spectrum of ovarian sex cord-stromal tumors; 20 years' retrospective study in a developing country. J Ovarian Res. 2013; 6(1):87. PMC: 4176297. DOI: 10.1186/1757-2215-6-87. View

13.

Mahdi H, Swensen R, Hanna R, Kumar S, Ali-Fehmi R, Semaan A . Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer. 2011; 105(4):493-7. PMC: 3170967. DOI: 10.1038/bjc.2011.267. View

14.

Brown J, Sood A, Deavers M, Milojevic L, Gershenson D . Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?. Gynecol Oncol. 2009; 113(1):86-90. DOI: 10.1016/j.ygyno.2008.12.007. View

15.

Smith H, Berwick M, Verschraegen C, Wiggins C, Lansing L, Muller C . Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006; 107(5):1075-85. DOI: 10.1097/01.AOG.0000216004.22588.ce. View

16.

Tangir J, Zelterman D, Ma W, Schwartz P . Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003; 101(2):251-7. DOI: 10.1016/s0029-7844(02)02508-5. View

17.

Lo Presti A, Ruvolo G, Gancitano R, Cittadini E . Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol. 2004; 113 Suppl 1:S33-40. DOI: 10.1016/j.ejogrb.2003.11.008. View

18.

Thomakos N, Malakasis A, Machairiotis N, Zarogoulidis P, Rodolakis A . Fertility Sparing Management in Non-Epithelial Ovarian Cancer. Which Patients, What Procedure and What Outcome?. J Cancer. 2018; 9(24):4659-4664. PMC: 6299391. DOI: 10.7150/jca.26674. View

19.

Ertas I, Taskin S, Goklu R, Bilgin M, Goc G, Yildirim Y . Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors. J Obstet Gynaecol Res. 2013; 40(3):797-805. DOI: 10.1111/jog.12253. View

20.

Vasta F, Dellino M, Bergamini A, Gargano G, Angelo Paradiso , Loizzi V . Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery. Biomedicines. 2020; 8(12). PMC: 7761340. DOI: 10.3390/biomedicines8120554. View